California has become a world-leader in stem cell research. News of California-based Biotechnology Company, International Stem Cell Corporation’s clinical trial spread rapidly through online and print news and social media.
The California Institute for Regenerative Medicine is working on treatments for 40 different diseases like Alzheimer, Parkinson, Diabetes, Rheumatoid Arthritis, Multiple Sclerosis and many other inflammatory and degenerative diseases. Several projects have already led to clinical trials; which means that are being tested in people, and there are several others that are on track to go into clinical trials in the next year or so.
The California Institute for Regenerative Medicine In the 18 months since its board invested $24 million to kick-start the first three Alpha Clinics the Network has signed up 21 clinical trials.
The University of Southern California is working to translate the potential of stem cell research to the clinical imperative of regenerative medicine. Researchers from across the university, including the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the Keck School of Medicine are exploring the normal mechanisms that build, maintain and repair our body systems, to develop alternative treatments for irreversible injuries like myocardial infarction, spinal cord injury, osteoarthritis and many others.
Although there are FDA-regulated clinical studies approved for now, there are no stem cells therapies legally available in the United State.
Despite all efforts, in California; cell research is in its infancy yet and treatments are not legally available, that is why Stem Cells Transplant Institute in Costa Rica wants to offer our patients from San Diego, San Francisco, Marin, Los Angeles, Santa Clara, San Mateo and many other cities in California, legally approved therapies, so you wont have to wait years to hear about how Regenerative Medicine has changed someone else´s quality of life. Are you ready to be a living proof? Apply here